Would it also be prudent to exclude the BARDA 'other income' in projections? I don't imagine the funding will be there forever and it's already being reduced.
When I read about the market opportunity and AVH's position within it I was excited that their growth plans have a decent chance of materialising, however the current valuation is a turnoff.
The next 12 months are key for investors to see if the enormous cost base can be scaled as the share price is predicting. I'd be happy to wait and pay a higher price if I can see the sales trajectory continuing and EBITDA losses trending downward.
Otherwise I'll wait for the next CR which should be around 35-40c in my opinion,
Ann: Appendix 4E and Preliminary Final Report, page-17
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.03 |
Change
0.070(2.36%) |
Mkt cap ! $213.6M | |||
| Open | High | Low | Value | Volume |
| $3.05 | $3.09 | $3.00 | $281.2K | 92.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2681 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.07 | 21000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |